The findings are important given concerns raised about the long-term impact of stimulant treatment on substance abuse in general and cigarette smoking in particular.
Conventional stimulant medications for attention-deficit hyperactivity disorder (ADHD) may have a secondary benefit; they may lower smoking rates in youth. As discussed online in the journal Pediatrics, Duke Medicine researchers say the association is especially apparent when medication is taken consistently. “Given that individuals with ADHD are more likely to smoke, our study supports the […]
Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis. ADHD is a common childhood disorder that can continue through adolescence and adulthood, and is characterized by hyperactivity, difficulty paying attention and impulsivity. It is most commonly treated with stimulant medication (such as Vyvanse or Concerta), as well as with behavior therapy or a combination of the two.
Treatment for attention deficit hyperactivity disorder, or ADHD, may reduce the risk that a child will become a smoker as an adult. ADHD, marked by hyperactive and impulsive behavior, is treated with stimulant medications (including Vyvanse and Concerta). Studies have shown that adults with ADHD are twice as likely to smoke as those without the condition. People with ADHD also start earlier as …